Corrado Tamburino1,2, MD, PhD; Davide Capodanno1,2*, MD, PhD; Maria Elena Di Salvo1, MD; Alessandra Sanfilippo1, MD; Irene Cascone1, MD; Valentina Incardona1, MD; Giovanni Longo1, MD; Daniele Giacoppo1, MD; Piera Capranzano1, MD; Carmelo Sgroi1, MD; Gianpaolo Ussia1, MD; Alfio Monaco1, MD; Alessio La Manna1, MD
1. Cardiovascular Department, Ferrarotto Hospital, Catania, Italy; 2. ETNA Foundation, Catania, Italy
Aims: The pivotal ATLANTA first-in-man study showed the promising safety and efficacy profile of the novel Catania™ stent in a population with ~20% American College of Ca